|
|
|||||
|
Neurochem successfully closed its first public offering on June 22, 2000. The Company
was officially listed on that day on the
Toronto Stock Exchange
under the symbol "NRM". (NRM.TO) Annual Meeting The Annual and Special Meeting of Shareholders will be held at 10:00 A.M. on April 15, 2008, in the Maxwell Cummings Auditorium of the Michal and Renata Hornstein Pavilion of the Montreal Museum of Fine Arts, located at 1379 Sherbrooke Street West, Montreal, Quebec.
- Management's discussion and analysis of consolidated - Financial statements
- Management's discussion and analysis of consolidated - Financial statements
- Management's discussion and analysis of consolidated - Financial statements
- Management's discussion and analysis of consolidated - Financial statements Back to the top Year ending December 31, 2007 - Third quarter ended September 30, 2007 - Second quarter ended June 30, 2007 - First quarter ended March 31, 2007 Year ended December 31, 2006 - Third quarter ended September 30, 2006 - Second quarter ended June 30, 2006 - First quarter ended March 31, 2006 Year ended December 31, 2005 - Third quarter ended September 30, 2005 - Second quarter ended June 30, 2005 - First quarter ended March 31, 2005 Back to the top
In Canada
David Dean
Cormark Securities Inc.
Analyst to be determined
Loewen, Ondaatje, McCutcheon Limited
Philippa Flint
RBC Capital Markets
In the United States
Brian Lian
CIBC World Markets
Patrick Moriarty
Fortis Securities LLC
Elemer Piros
Rodman & Renshaw Back to the top
Some of the latest articles on Neurochem's achievements, in general
and scientific publications: New England Journal of Medicine
356:2349, June 7, 2007 Neurobiology of Aging
Volume 28, Issue 4, April 2007 Neurology
November 2006, vol. 67, no. 10 Medical Marketing & Media
August 2006 Newsweek
Summer 2005, Your Health Special Edition Nature
August 2004, vol.430 BioWorld Today
August 12, 2004, vol.15, no.155 Reuters Health
August 6, 2004 Neuron
August 5, 2004 Script Report
July 2004 The Wall Street Journal
June 29, 2004 Commerce
March 2004 (P.74) Biotechnology Focus
February 2004, Vol. 7, No. 2 (pp. 17-20) Back to the top |
||
|
Computershare Investor Services
100 University Avenue, |
||
|
Auditors: |
KMPG L.L.P.
600, De Maisonneuve Blvd. West |
|
|
Back to the top
For further information, please contact: |
||
|
Our site is best viewed with IE4+ at a resolution of 1024×768. |
|